T

T3 Pharmaceuticals AG

12 employees

T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.

Basic info

Industry

biotechnology

Sectors

Bacterial cancer therapy
Biotechnology
Cancer therapy
Therapeutics
Protein delivery
Life Science

Date founded

2015

Funding rounds raised

Total raised

$27M

from 5 investors over 5 rounds

T

T3 Pharmaceuticals AG raised undisclosed on April 28, 2023

Investors: Innosuisse - Schweizerische Agentur für Innovationsförderung

T

T3 Pharmaceuticals AG raised undisclosed on June 10, 2021

Investors: Swiss Economic Forum

T

T3 Pharmaceuticals AG raised $27M on July 22, 2020

Investors: Reference Capital and Wille Finance

T

T3 Pharmaceuticals AG raised $12M on September 26, 2019

Investors: Reference Capital

FAQ